Gunnar Gislason
Gunnar Gislason
Professor of Cardiology, Gentofte Hospital University of Copenhagen
Bekræftet mail på regionh.dk
TitelCiteret afÅr
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study
JB Olesen, GYH Lip, ML Hansen, PR Hansen, JS Tolstrup, J Lindhardsen, ...
Bmj 342, d124, 2011
11452011
Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation
ML Hansen, R Sørensen, MT Clausen, ML Fog-Petersen, J Raunsø, ...
Archives of internal medicine 170 (16), 1433-1441, 2010
7912010
Association of national initiatives to improve cardiac arrest management with rates of bystander intervention and patient survival after out-of-hospital cardiac arrest
M Wissenberg, FK Lippert, F Folke, P Weeke, CM Hansen, ...
Jama 310 (13), 1377-1384, 2013
7612013
Stroke and bleeding in atrial fibrillation with chronic kidney disease
JB Olesen, GYH Lip, AL Kamper, K Hommel, L Køber, DA Lane, ...
New England Journal of Medicine 367 (7), 625-635, 2012
6782012
Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective …
R Sørensen, ML Hansen, SZ Abildstrom, A Hvelplund, C Andersson, ...
The Lancet 374 (9706), 1967-1974, 2009
5352009
CLINICAL PERSPECTIVE
TK Schramm, GH Gislason, L Køber, S Rasmussen, JN Rasmussen, ...
Circulation 117 (15), 1945-1954, 2008
5142008
CLINICAL PERSPECTIVE
GH Gislason, S Jacobsen, JN Rasmussen, S Rasmussen, P Buch, ...
Circulation 113 (25), 2906-2913, 2006
5052006
Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a ‘real world’nationwide cohort study
JB Olesen, GYH Lip, J Lindhardsen, DA Lane, O Ahlehoff, ML Hansen, ...
Thrombosis and haemostasis 106 (10), 739-749, 2011
4782011
Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction …
TK Schramm, GH Gislason, A Vaag, JN Rasmussen, F Folke, ML Hansen, ...
European heart journal 32 (15), 1900-1908, 2011
4742011
Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention …
M Lamberts, JB Olesen, MH Ruwald, CM Hansen, D Karasoy, ...
Circulation 126 (10), 1185-1193, 2012
4082012
Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study
O Ahlehoff, GH Gislason, M Charlot, CH Jørgensen, J Lindhardsen, ...
Journal of internal medicine 270 (2), 147-157, 2011
3522011
Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a …
AM Schjerning Olsen, EL Fosbøl, J Lindhardsen, F Folke, M Charlot, ...
Circulation 123 (20), 2226-2235, 2011
3502011
Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention
M Lamberts, GH Gislason, JB Olesen, SL Kristensen, AMS Olsen, ...
Journal of the American College of Cardiology 62 (11), 981-989, 2013
3302013
The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study
J Lindhardsen, O Ahlehoff, GH Gislason, OR Madsen, JB Olesen, ...
Annals of the rheumatic diseases 70 (6), 929-934, 2011
3242011
Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction
GH Gislason, JN Rasmussen, SZ Abildstrøm, N Gadsbøll, P Buch, ...
European heart journal 27 (10), 1153-1158, 2006
2992006
Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke
DP Hopkins, PA Briss, CJ Ricard, CG Husten, VG Carande-Kulis, ...
American journal of preventive medicine 20 (2), 16-66, 2001
2892001
Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure
GH Gislason, JN Rasmussen, SZ Abildstrom, TK Schramm, ML Hansen, ...
Archives of internal medicine 169 (2), 141-149, 2009
2822009
Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study
M Charlot, O Ahlehoff, ML Norgaard, CH Jørgensen, R Sørensen, ...
Annals of internal medicine 153 (6), 378-386, 2010
2682010
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ...
The Lancet 391 (10117), 219-229, 2018
2662018
Cause-specific cardiovascular risk associated with nonsteroidal antiinflammatory drugs among healthy individuals
EL Fosbøl, F Folke, S Jacobsen, JN Rasmussen, R Sørensen, ...
Circulation: Cardiovascular Quality and Outcomes 3 (4), 395-405, 2010
2112010
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20